Erythropoietin: evolving clinical applications.
Abels
R I
RI
R.W. Johnson Pharmaceutical Research Institute, Raritan, New Jersey 08869.
Rudnick
S A
SA
D000740:Anemia / Q000188:drug therapy*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy; D004921:Erythropoietin / Q000009:adverse effects / Q000493:pharmacokinetics / Q000502:physiology / Q000627:therapeutic use*; D006801:Humans; D007231:Infant, Newborn; D007235:Infant, Premature, Diseases / Q000188:drug therapy; D011994:Recombinant Proteins
D011994:Recombinant Proteins; D004921:Erythropoietin